| related words |
| vaccine |
| therapeutic |
| commercialized |
| novel |
| stent |
| tarceva |
| bidil |
| recothrom |
| investigational |
| cubicin |
| gene |
| labeling |
| marketed |
| safer |
| hematide |
| multiferon |
| investigator |
| zegerid |
| formulation |
| nda |
|
| related documents |
| 1088856--3/26/2010--CORCEPT_THERAPEUTICS_INC |
| 1098972--3/16/2009--ANTIGENICS_INC_/DE/ |
| 1002637--2/29/2008--MILLENNIUM_PHARMACEUTICALS_INC |
| 1002637--3/8/2006--MILLENNIUM_PHARMACEUTICALS_INC |
| 1002637--3/1/2007--MILLENNIUM_PHARMACEUTICALS_INC |
| 919722--3/16/2006--SUPERGEN_INC |
| 716054--3/16/2009--CYPRESS_BIOSCIENCE_INC |
| 350832--12/20/2010--AMERICAN_PACIFIC_CORP |
| 1347178--3/15/2010--Vanda_Pharmaceuticals_Inc. |
| 881524--3/10/2010--VIVUS_INC |
| 1183765--3/8/2010--THRESHOLD_PHARMACEUTICALS_INC |
| 1080014--2/26/2010--THERAVANCE_INC |
| 1034842--3/2/2010--RIGEL_PHARMACEUTICALS_INC |
| 707511--3/31/2010--REGENERX_BIOPHARMACEUTICALS_INC |
| 1012140--2/23/2010--ONYX_PHARMACEUTICALS_INC |
| 69499--2/26/2010--MYLAN_INC. |
| 1087432--3/15/2010--INTERMUNE_INC |
| 879169--3/5/2010--INCYTE_CORP |
| 727510--3/12/2010--ENZON_PHARMACEUTICALS_INC |
| 805326--3/25/2010--EMISPHERE_TECHNOLOGIES_INC |
|
| related topics |
| {product, candidate, development} |
| {cost, regulation, environmental} |
| {product, liability, claim} |
| {property, intellectual, protect} |
| {customer, product, revenue} |
| {condition, economic, financial} |
| {financial, litigation, operation} |
| {product, market, service} |
| {gas, price, oil} |
| {stock, price, operating} |
| {provision, law, control} |
| {debt, indebtedness, cash} |
| {acquisition, growth, future} |
| {system, service, information} |
| {interest, director, officer} |
| {cost, operation, labor} |
| {competitive, industry, competition} |
| {loss, insurance, financial} |
| {regulation, government, change} |
| {cost, contract, operation} |
|